Dr. Deepak Chellapandian, MD
Claim this profileJohns Hopkins All Children's Hospital
Area of expertise
Primary Immunodeficiency
Deepak Chellapandian, MD has run 1 trial for Primary Immunodeficiency. Some of their research focus areas include:
Metabolic Diseases
Deepak Chellapandian, MD has run 1 trial for Metabolic Diseases. Some of their research focus areas include:
Affiliated Hospitals
Johns Hopkins All Children's Hospital
Clinical Trials Deepak Chellapandian, MD is currently running
Haploidentical HCT
for Primary Immunodeficiency
This research is being done to learn if a new type of haploidentical transplantation using TCR alpha beta and CD19 depleted stem cell graft from the donor is safe and effective to treat the patient's underlying condition. This study will use stem cells obtained via peripheral blood or bone marrow from parent or other half-matched family member donor. These will be processed through a special device called CliniMACS, which is considered investigational.
Recruiting
2 awards
Phase 2
Haploidentical Stem Cell Transplant
for Blood Diseases
This research is being done to learn if a new type of haploidentical transplantation using TCR alpha beta and CD19 depleted stem cell graft from the donor is safe and effective to treat the patient's underlying condition. This study will use stem cells obtained via peripheral blood or bone marrow from parent or other half-matched family member donor. These will be processed through a special device called CliniMACS, which is considered investigational.
Recruiting
2 awards
Phase 2
More about Deepak Chellapandian, MD
Clinical Trial Related
5 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Deepak Chellapandian, MD has experience with
- Haploidentical Hematopoietic Cell Transplantation
- TCR Alpha Beta T-cell Depleted Haploidentical HCT
Breakdown of trials Deepak Chellapandian, MD has run
Primary Immunodeficiency
Metabolic Diseases
Iron and Trace Metal Metabolism Disorders
Bone Marrow Failure Syndrome
Sickle Cell Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Deepak Chellapandian, MD specialize in?
Deepak Chellapandian, MD focuses on Primary Immunodeficiency and Metabolic Diseases. In particular, much of their work with Primary Immunodeficiency has involved HLA-A positive patients, or patients who are HLA-A negative.
Is Deepak Chellapandian, MD currently recruiting for clinical trials?
Yes, Deepak Chellapandian, MD is currently recruiting for 2 clinical trials in Saint Petersburg Florida. If you're interested in participating, you should apply.
Are there any treatments that Deepak Chellapandian, MD has studied deeply?
Yes, Deepak Chellapandian, MD has studied treatments such as Haploidentical Hematopoietic Cell Transplantation, TCR Alpha Beta T-cell Depleted Haploidentical HCT.
What is the best way to schedule an appointment with Deepak Chellapandian, MD?
Apply for one of the trials that Deepak Chellapandian, MD is conducting.
What is the office address of Deepak Chellapandian, MD?
The office of Deepak Chellapandian, MD is located at: Johns Hopkins All Children's Hospital, Saint Petersburg, Florida 33701 United States. This is the address for their practice at the Johns Hopkins All Children's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.